Thanks for that in depth response Kit.Still tempted on a 12-18 month view, but agree share price could get worse before it gets better.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025